Stromacare

Developer of immunotherapy for the treatment of solid tumors

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2020 groups9 employees language stroma.care

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 105 times.

YearFilings
20251

Social engagement

Social engagement: 1.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Turenne Groupe, Kreaxi.

Investor typeCountShare
Venture capital125%
Private equity250%
Other / undisclosed125%

Recent activity

14 Oct 2025
Event
Future for Health
Coming soon